Sunday, September 20, 2009 3:03:53 AM
http://www.nasdaq.com/aspx/company-news-story.aspx?storyid=200909181720rttraderusequity_0917&title=nucryst-pharma-gets-deficiency-notice-from-nasdaq---quick-facts
(RTTNews) - Nucryst Pharmaceuticals Corp. (NCST) said that on September 15, 2009 it received notice from the Nasdaq Stock Market that it no longer complies with Nasdaq Marketplace Rule because, for the previous 30 consecutive business days, the bid price of its common stock had closed below the minimum requirement of $1.00 per share. In accordance with Marketplace Rule, the company has until March 15, 2010 to regain compliance, which requires a closing bid price of the company's common stock at or above $1.00 per share for a minimum of 10 consecutive business days.
http://www.nasdaq.com/aspx/company-news-story.aspx?storyid=200909181720rttraderusequity_0917&title=nucryst-pharma-gets-deficiency-notice-from-nasdaq---quick-facts
Closed at $0.96 on Friday. Back in March of this year NCST was at $0.30. Sure hope this uptrend continues.
cooler
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM